1
Registered trials
0
Recruiting
1
Unique sponsors
2
Unique IMPs
0
Commercial trials
Drug classes (ATC)
L
Oncology (ATC L)
1
Mechanism of action (INN-stem analysis)
Checkpoint inhibitor (PD-L1)
1 substance
Checkpoint inhibitor (CTLA-4)
1 substance
Phase I/II:
1
Phase I/II
1 trial-
EndedInstitut Gustave Roussy AcademicDURVALUMAB; TREMELIMUMAB
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Institut Gustave Roussy | Academic | 1 | Phase I/II | 0 |